Acute disease

disease
On this page

Also known as acute diseasesdisease, acute

Summary

Acute disease (MONDO:0020683) is a disease (an umbrella term covering 119 Mondo subtypes) and 47 clinical trials. Top therapeutic interventions include abciximab, ascorbic acid, and ertapenem. A subtype of human disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Umbrella term: 119 Mondo subtypes
  • Clinical trials: 47

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameacute disease
Mondo IDMONDO:0020683
MeSHD000208
SNOMED CT2704003
UMLSC0001314
MedGen1738
Is cancer (heuristic)no

Also known as: acute disease · acute diseases · disease, acute

Disease family

An umbrella term covering 119 Mondo subtypes.

Classification path: disease › human disease › acute disease

Related subtypes (3): disease by body system or component, disease by developmental or physiological process, disease by etiologic mechanism

Subtypes (119): encephalopathy, acute, infection-induced, seminal vesicle acute gonorrhea, acute diarrhea, acute hydrops keratoconus, acute pericementitis, purulent acute otitis media, acute otitis externa, acute eustachian salpingitis, acute cervicitis, acute gonococcal epididymo-orchitis, acute salpingitis, acute respiratory failure, acute conjunctivitis, acute laryngopharyngitis, acute orbital inflammation, acute dacryocystitis, acute sphenoidal sinusitis, acute proliferative glomerulonephritis, acute cystitis, acute tympanitis, acute closed-angle glaucoma, acute gonococcal prostatitis, acute poststreptococcal glomerulonephritis, acute diffuse glomerulonephritis, acute retrobulbar neuritis, acute frontal sinusitis, acute cholangitis, acute thyroiditis, acute maxillary sinusitis, acute kidney injury, acute transudative otitis media, acute myocarditis, subacute glomerulonephritis, acute pyelonephritis, acute urate nephropathy, acute stress disorder, acute inflammation of lacrimal passage, acute endometritis, acute cor pulmonale, acute intestinal ischemia, subacute delirium, acute laryngitis, acute myocardial infarction, acute ethmoiditis, acute dacryoadenitis, acute female pelvic peritonitis, acute quadriplegic myopathy, severe acute respiratory syndrome, acute hypotension, acute coronary syndrome, acute chest syndrome, acute pancreatitis, acute retinal necrosis syndrome, subacute bacterial endocarditis, necrotizing encephalomyelopathy, subacute, of Leigh, adult, acute intermittent porphyria, leukemia, acute myelocytic, with polyposis coli and colon cancer, surfactant metabolism dysfunction, pulmonary, 1, myoglobinuria, acute recurrent, autosomal recessive, acute leukemia, acute insulin response, alcohol sensitivity, acute, leukemia, acute lymphocytic, susceptibility to, 1, leukemia, acute lymphocytic, susceptibility to, 2, acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, acute transverse myelitis, subacute cutaneous lupus erythematosus, acute lung injury, subacute inflammatory demyelinating polyneuropathy, Marburg acute multiple sclerosis, acute pure sensory neuropathy, autoimmune autonomic ganglionopathy, acute sensory ataxic neuropathy, acute fatty liver of pregnancy, acute neonatal citrullinemia type I, acute endophthalmitis, acute zonal occult outer retinopathy, acute annular outer retinopathy, poliomyelitis, acute generalized exanthematous pustulosis, acute opioid poisoning, acute encephalopathy with biphasic seizures and late reduced diffusion, acute tricyclic antidepressant poisoning, acute poisoning by drugs with membrane-stabilizing effect, recurrent acute pancreatitis, bilateral acute depigmentation of the iris, idiopathic acute eosinophilic pneumonia, acute ackee fruit intoxication, acute interstitial pneumonia, acute liver failure, acute adrenal insufficiency, encephalitis, acute inflammatory demyelinating polyradiculoneuropathy, acute motor and sensory axonal neuropathy, acute motor axonal neuropathy, acute graft versus host disease, acute pharyngitis, sudden hearing loss disorder, acute bronchiolitis, acute tonsillitis, acute rheumatic heart disease, acute cholinergic dysautonomia, acute mountain sickness, acute lymphoblastic leukemia congenital sporadic aniridia, acute lichenoid pityriasis, leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, acute radiation syndrome, acute bilirubin encephalopathy, acute mast cell leukemia, subacute bursitis, acute papillary necrosis, acute posterior multifocal placoid pigment epitheliopathy, acute idiopathic urticaria, acute macular neuroretinopathy, acute flaccid myelitis, acute hepatitis B virus infection, acute hepatitis C virus infection, acute fibrinous and organizing pneumonia, acute transplant rejection

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

Drugs indicated or in trials for this disease

No drug has an approved disease-direct ChEMBL indication for this disease.

2 drugs in clinical trials for this disease (phase 2–3, investigational): efficacy not established — a trial record, not an indication.

DrugHighest phase
AbciximabPhase 3
BivalirudinPhase 3

Clinical trials & evidence

Clinical trials

Clinical trials: 47.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified40
PHASE42
PHASE32
PHASE22
PHASE2/PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00097734PHASE4UNKNOWNStudy to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis
NCT01050478PHASE4COMPLETEDIMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation
NCT06949228PHASE2/PHASE3RECRUITINGAdjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
NCT00073372PHASE3TERMINATEDA Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)
NCT00093158PHASE3COMPLETEDComparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
NCT00607997PHASE2COMPLETEDStudy of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia
NCT00715962PHASE2COMPLETEDEfficacy and Safety of a Hospital Walking Program for Older Adults
NCT04420832Not specifiedACTIVE_NOT_RECRUITINGAcute Achilles Tendon Rupture - Choice of Treatment Based on Ultrasound Findings
NCT04615065Not specifiedRECRUITINGAcutelines: a Large Data-/Biobank of Acute and Emergency Medicine
NCT05913700Not specifiedACTIVE_NOT_RECRUITINGEffect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
NCT06315842Not specifiedNOT_YET_RECRUITINGLevels of Diagnostic and Therapeutic Intervention in Hospitalized Patients
NCT06655337Not specifiedRECRUITINGEfficiency of the Medidux Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)
NCT06901167Not specifiedRECRUITINGEvaluation of a Residential In-Reach Program in Regional and Rural Australia
NCT06983847Not specifiedRECRUITINGA Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency
NCT07007156Not specifiedRECRUITINGIs a Positive NECPAL in ICU Patients Associated With Higher Mortality
NCT07278648Not specifiedNOT_YET_RECRUITINGHigh-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department
NCT07472335Not specifiedNOT_YET_RECRUITINGHome-based Acute Care for Older Persons Initiated by the Emergency Medical and Ambulance Services - a Retrospective Observation of Effects on Healthcare Utilisation and Mortality
NCT00186342Not specifiedCOMPLETEDSibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
NCT00461201Not specifiedUNKNOWNNurse vs General Practitioner Care for Patients Requesting Same Day Consultations in Primary Care
NCT00563654Not specifiedTERMINATEDRandomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
NCT01108172Not specifiedUNKNOWNA Virtual Ward to Reduce Readmissions After Hospital Discharge
NCT01278199Not specifiedCOMPLETEDBronchial Artery Embolization and Medical Measures in Non Severe Acute Hemoptysis of Mild-moderate Abundance
NCT01506180Not specifiedCOMPLETEDIn-Hospital Comprehensive Geriatric Assessment in Aged Acute Medical Patients
NCT02422901Not specifiedUNKNOWNA Long-term Study to Describe the Use of PASCORBIN® 7.5 g in Patients With Vitamin C Deficiency
NCT02474277Not specifiedCOMPLETEDHow Well Does the 30-Second Chair Stand Test Predict Rehabilitation Needs in Acutely Admitted Elderly Patients
NCT02533869Not specifiedCOMPLETEDThe Optimization of a Low-dose Computed Tomography Protocol in Patients With Suspected Uncomplicated Acute Appendicitis
NCT02568475Not specifiedCOMPLETEDInvolving Nursing Home Residents and Their Families in Acute Care Transfer Decisions
NCT02688244Not specifiedUNKNOWNIrrigation Versus Suction in Complicated Acute Appendicitis
NCT02800122Not specifiedUNKNOWNPAthwAy of Dyspneic patIent in Emergency (PArADIsE)
NCT02912624Not specifiedCOMPLETEDSimple Intensive Care Studies I (SICS-I)
NCT02915640Not specifiedCOMPLETEDUse of a Mobile Remote Device to Optimize Pediatric Inter-facility Transportation: A Feasibility Study
NCT02917213Not specifiedCOMPLETEDImaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
NCT03175692Not specifiedUNKNOWNRapid Genetic Diagnosis Employing Next Generation Sequencing for Critical Illness in Infants and Children
NCT03553069Not specifiedCOMPLETEDSimple Observational Critical Care Studies
NCT03607084Not specifiedCOMPLETEDSchool-based Health Programs on Children’s Wellbeing in Lusaka, Zambia
NCT03832257Not specifiedCOMPLETEDImproving Safety of Transitions to Skilled Nursing Care Using Videoconferencing
NCT03892850Not specifiedUNKNOWNEffectiveness and Safety of the Nursing Prescription in Acute Health Problems of Low Complexity
NCT03982589Not specifiedCOMPLETEDTelomere Length in Relation to Acute Stress Response in Critical Care Patients
NCT04326387Not specifiedUNKNOWNEvaluation of Novel Diagnostic Tests for COVID-19
NCT04519086Not specifiedSUSPENDEDThe Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
ABCIXIMAB41
ASCORBIC ACID41
ERTAPENEM41
FIBRINOGEN I 12541
TENECTEPLASE41
BENZODIAZEPINE31
VOSAROXIN31